<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Transl Radiat Oncol</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Transl Radiat Oncol</journal-id>
<journal-title-group>
<journal-title>Clinical and Translational Radiation Oncology</journal-title>
</journal-title-group>
<issn pub-type="epub">2405-6308</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29594229</article-id>
<article-id pub-id-type="pmc">5862639</article-id>
<article-id pub-id-type="publisher-id">S2405-6308(17)30036-8</article-id>
<article-id pub-id-type="doi">10.1016/j.ctro.2017.10.001</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Radiomic analysis in prediction of Human Papilloma Virus status</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Kaixian</given-names>
</name>
<xref ref-type="aff" rid="af005">a</xref>
<xref ref-type="fn" rid="fn1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Youyi</given-names>
</name>
<xref ref-type="aff" rid="af005">a</xref>
<xref ref-type="fn" rid="fn1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="af015">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="af010">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Rongjie</given-names>
</name>
<xref ref-type="aff" rid="af005">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Tengfei</given-names>
</name>
<xref ref-type="aff" rid="af005">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Liuqing</given-names>
</name>
<xref ref-type="aff" rid="af015">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morris</surname>
<given-names>Jeffrey S.</given-names>
</name>
<xref ref-type="aff" rid="af005">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baladandayuthapani</surname>
<given-names>Veerabhadran</given-names>
</name>
<xref ref-type="aff" rid="af005">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Hongtu</given-names>
</name>
<email>hzhu5@mdanderson.org</email>
<xref ref-type="aff" rid="af005">a</xref>
<xref ref-type="corresp" rid="cor1">⁎</xref>
</contrib>
</contrib-group>
<aff id="af005"><label>a</label>Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, United States</aff>
<aff id="af010"><label>b</label>Department of Biostatistics, University of North Carolina at Chapel Hill, United States</aff>
<aff id="af015"><label>c</label>Department of Statistics and Operations Research, University of North Carolina at Chapel Hill, United States</aff>
<author-notes>
<corresp id="cor1"><label>⁎</label>Corresponding author. <email>hzhu5@mdanderson.org</email></corresp>
<fn id="fn1">
<label>1</label>
<p id="np005">These authors contribute equally.</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>11</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>7</volume>
<fpage>49</fpage>
<lpage>54</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 The Authors</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="ab005">
<p>Human Papilloma Virus (HPV) has been associated with oropharyngeal cancer prognosis. Traditionally the HPV status is tested through invasive lab test. Recently, the rapid development of statistical image analysis techniques has enabled precise quantitative analysis of medical images. The quantitative analysis of Computed Tomography (CT) provides a non-invasive way to assess HPV status for oropharynx cancer patients. We designed a statistical radiomics approach analyzing CT images to predict HPV status. Various radiomics features were extracted from CT scans, and analyzed using statistical feature selection and prediction methods. Our approach ranked the highest in the 2016 Medical Image Computing and Computer Assisted Intervention (MICCAI) grand challenge: Oropharynx Cancer (OPC) Radiomics Challenge, Human Papilloma Virus (HPV) Status Prediction. Further analysis on the most relevant radiomic features distinguishing HPV positive and negative subjects suggested that HPV positive patients usually have smaller and simpler tumors.</p>
</abstract>
<kwd-group id="kg005">
<title>Keywords</title>
<kwd>Radiomics</kwd>
<kwd>CT image</kwd>
<kwd>HPV status</kwd>
<kwd>Oropharynx cancer</kwd>
<kwd>Statistical method</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s0015">
<title>Introduction</title>
<p id="p0005">Oropharyngeal cancer prognosis is often linked with Human Papilloma Virus (HPV), especially HPV type 16. HPV associated oropharynx cancer patients have been shown to have increased survival time and better tumor control with radiotherapy than non-HPV-associated ones <xref ref-type="bibr" rid="b0005">[1]</xref>, <xref ref-type="bibr" rid="b0010">[2]</xref>, <xref ref-type="bibr" rid="b0015">[3]</xref>. Typically, HPV status is tested using immunohistochemistry for p16, a protein, or in situ hybridization for viral DNA. However, the lab testing usually requires collecting biospecimen from the patients, thus it is invasive and may impose potential risk to the patients. Therefore, seeking non-invasive yet accurate way to assess the HPV status becomes important. One possible solution is through the low dose computed tomography (CT) scans which is done routinely for screening, diagnosis, and treatment guidance. A low dose CT scan is non-invasive, and it is less likely to impose extra risks to testees. Besides non-invasiveness, the imaging technique could help the physician collect more information at diagnose which subsequently will improve the design of treatment, makes the treatment more precise for each patient.</p>
<p id="p0010">Recently, the rapid development of radiomics has enabled more meaningful and precise quantitative analysis of medical images in various body sites. Magnetic Resonance Imaging (MRI) of brain has been extensively studied over the past two decades, many efforts have been done to quantify the relationship between radiomic features of MRI and the diagnosis of Alzheimer’s disease <xref ref-type="bibr" rid="b0020">[4]</xref>, <xref ref-type="bibr" rid="b0025">[5]</xref>, <xref ref-type="bibr" rid="b0030">[6]</xref>, <xref ref-type="bibr" rid="b0035">[7]</xref>, <xref ref-type="bibr" rid="b0040">[8]</xref> as well as risk of Autism <xref ref-type="bibr" rid="b0045">[9]</xref>. CT image is another important image modality that has been widely studied to built its connection with clinical outcomes. CT scan plays a critical role in early detection and prognosis for different types of cancer <xref ref-type="bibr" rid="b0050">[10]</xref>, <xref ref-type="bibr" rid="b0055">[11]</xref>, <xref ref-type="bibr" rid="b0060">[12]</xref>, <xref ref-type="bibr" rid="b0065">[13]</xref>. However, only a few studies have tried to connect the CT images with HPV status quantitatively, especially in oropharynx cancers. Cantrell and colleagues <xref ref-type="bibr" rid="b0070">[14]</xref> studied the radiomic differences in CT images between HPV+ and HPV−, but their study was not focused on predicting HPV status. Buch and colleagues <xref ref-type="bibr" rid="b0075">[15]</xref> analyzed the difference of 42 space-invariant texture features between HPV+ and HPV− patients, again this study did not come up with a predictive model for HPV+/−. Bogowicz and colleagues <xref ref-type="bibr" rid="b0080">[16]</xref> built a logistic regression distinguishing HPV+/− with radiomics features and achieved 0.78 AUC in validation cohort, but the number of radiomic features they used was still relative small, and not comprehensive enough. Besides that, the discovering cohort in their study was relative small.</p>
<p id="p0015">In this article, we describe an approach that utilizes only CT image to predict HPV status for oropharynx cancer patients. Our method won the first place among 9 participating teams in <italic>the 2016 Medical Image Computing and Computer Assisted Intervention (MICCAI) grand challenge: Oropharynx Cancer (OPC) Radiomics Challenge, Human Papilloma Virus (HPV) Status Prediction</italic>, with Area Under the Curve (AUC) 0.91549 in the held out evaluation data set. Our approach is based on statistical analysis of radiomic features of the upper chest CT. The feature selection result showed that among all the radiomic features extracted, <italic>MeanBreadth</italic> and <italic>SphericalDisproportion</italic> were the most important features that capture the most predictive radiomic information of the HPV status. We have also discovered that the results indicate that the HPV associated patients usually have smaller and simpler tumors. It is also worth mentioning that our method had a higher AUC in private leaderboard than the one in the public leaderboard, which indicates the proposed method is fairly generalizable.</p>
</sec>
<sec id="s0020">
<title>Materials and methods</title>
<p id="p0020">The analysis is based on radiomic features extracted from upper chest CT images, and prediction is assessed via statistical predictive models. The main challenges include extracting meaningful and predictive radiomic features, combining information across multiple Region Of Interests (ROI), selecting most relevant features, and constructing powerful predictive models. We have adopted existing state-of-the-art feature extraction method <xref ref-type="bibr" rid="b0085">[17]</xref> to obtain a set of radiomic features covering various aspects of the image, for example, shape, texture, and grayscale intensities. To handle the multi-ROI situation, we computed a “consensus” ROI that can be regarded as ROI representative for each feature and for each individual subject. Statistical methods, e.g. generalized linear model (GLM), random forest, tree based model, and etc., were employed to select the relevant features and make the final prediction. The general procedure is shown in <xref ref-type="fig" rid="f0005">Fig. 1</xref>.<fig id="f0005"><label>Fig. 1</label><caption><p>The overall procedure of the wining method.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
<sec id="s0025">
<title>Clinical and imaging data</title>
<p id="p0025">In this challenge, contrast-enhanced Computed Tomography (CT) scans of upper chest for 315 oropharynx cancer patients were provided as the radiomic dataset (detailed challenge setting and information of data acquisition, processing, and inclusion/exclusion, can be find in the challenge summary paper <xref ref-type="bibr" rid="b0090">[18]</xref>). 150 randomly selected subjects with annotated HPV status were given as training cohort, with 128 HPV positive and 22 HPV negative patients. The remaining 165 subjects were held out as a validation cohort (in the actual challenge, one half of the validation subjects were scored all through the last of the challenge as the public measure of the performance, and the other half were held out as a private score which was not released until the challenge was concluded). The human papilloma virus (HPV) status defined by p16, which was tested and provided by the organizers, is the main interest of this work. Two types of ROIs, Gross Primary/Nodal Tumor volume (GTVp/GTVn) are considered, and the ROI segmentation was done manually by board certified physicians in the organizers’ institution (University of Texas MD Anderson Cancer Center). In this challenge, we did not make distinguish between GTVp and GTVn per organizers’ suggestion.</p>
</sec>
<sec id="s0030">
<title>Pre-processing</title>
<p id="p0030">Several randomly selected 2D slices (5–10) of the CT images of each subject were manually inspected to assure the consistence of image quality. Subjects with low quality images including over-exposed and large degree of blurring were removed from the training cohort. We removed one subject (id: 88), since their CT scans were quite blurring in the main interested section, and the ROIs annotated were of volume 0.</p>
</sec>
<sec id="s0035">
<title>Radiomic feature extraction</title>
<p id="p0035">1683 radiomic features of 5 categories were extracted using IBEX <xref ref-type="bibr" rid="b0085">[17]</xref>, including Gray level cooccurrence matrix (GLCM 2D and 3D), Gray level run length matrix, intensity (and histogram), neighbor intensity difference (2D and 3D), and shape (for more details on parameters and feature types in each category please see <xref ref-type="sec" rid="s0010">Supplementary file 1</xref>). Quality control was done to ensure there is no missing values in extracted features. And the possible outliers, identified by Grubbs’ test <xref ref-type="bibr" rid="b0095">[19]</xref> were discarded.</p>
<p id="p0040">One critical problem in this dataset was that one subject often had more than one ROIs (GTVp or GTVn); therefore, a proper way to “choose” a representative ROI became important and essential to the prediction accuracy. Treating each ROI as an individual subject yields scientific and practical problems due to the fact that not all ROIs of a specific subject directly reflect HPV status. In this challenge, we designed a “consensus” ROI for each subject: if there was only one ROI for some subject, then we used that ROI to represent the subject; if there were more than one ROIs for a subject, we created a virtual ROI, the ROI still had the same set of features, but the values of the features were not necessary from the same ROI but rather taking the most extreme value (extremum, in terms of magnitude) comparing to the robust median of all ROIs of all subjects in the cohort (an example is given in <xref ref-type="fig" rid="f0010">Fig. 2</xref>).<fig id="f0010"><label>Fig. 2</label><caption><p>The creation of consensus ROI out of a subject with 3 ROIs.</p></caption><graphic xlink:href="gr2"></graphic></fig></p>
</sec>
<sec id="s0040">
<title>Statistical analysis</title>
<p id="p0045">The general statistical analysis is outlined as follows:<list id="l0005" list-type="simple"><list-item id="o0005"><label>1.</label><p id="p0120">Homogeneous testing between training and validation cohorts was done by Wilcoxon-rank-sum test <xref ref-type="bibr" rid="b0100">[20]</xref>, <xref ref-type="bibr" rid="b0105">[21]</xref> for each feature. The features with <italic>p</italic>-value &lt;0.05 were discarded due to their inhomogeneity, which will subsequently affect the predictive model built from the training cohort.</p></list-item><list-item id="o0010"><label>2.</label><p id="p0125">Preliminary feature screening was done by Kolmogorov–Smirnov (KS) test <xref ref-type="bibr" rid="b0110">[22]</xref>, <xref ref-type="bibr" rid="b0115">[23]</xref>. For each feature, calculating the KS statistic between HPV+ and HPV− subjects in the training cohort, keep only the features with <italic>p</italic>-value &lt;0.05 to select only the features that were able to distinguish the two groups.</p></list-item><list-item id="o0015"><label>3.</label><p id="p0130">Further feature screening through correlation with HPV status. A biserial correlation between HPV status and each radiomic feature was calculated, and only the features with biserial absolute correlation &gt;0.3 were kept to achieve clinical relevance.</p></list-item><list-item id="o0020"><label>4.</label><p id="p0135">Ranking remaining features by their marginal Area Under Curve (AUC) obtained by 10-time random split. The marginal AUC was accessed by building model with only one feature. The random split was done by randomly sampling 50<inline-formula><mml:math altimg="si1.gif" id="M1" overflow="scroll"><mml:mrow><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of the training cohort to train the model, then evaluating on the held out <inline-formula><mml:math altimg="si3.gif" id="M2" overflow="scroll"><mml:mrow><mml:mn>50</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> data. We have tested various statistical models, including generalized linear model (GLM) <xref ref-type="bibr" rid="b0120">[24]</xref>, pdfCluster <xref ref-type="bibr" rid="b0125">[25]</xref>, predictive tree model <xref ref-type="bibr" rid="b0130">[26]</xref>, random forest <xref ref-type="bibr" rid="b0135">[27]</xref>, Support Vector Machine (SVM) <xref ref-type="bibr" rid="b0140">[28]</xref>, and etc. Only the top 10 features with highest marginal AUC were kept in this step.</p></list-item><list-item id="o0025"><label>5.</label><p id="p0140">The final features in the model was selected by forward selection, where we add features one by one according to their ranks of marginal AUC from high to low, until the model AUC stopped increasing. The model AUC was accessed by 10-time random split as well.</p></list-item></list></p>
<p id="p0050">Selecting appropriate statistical model (tree, GLM, SVM,…) was done by submitting to the public leaderboard of this challenge, as well tuning some parameters. e.g. number of trees in random forest.</p>
</sec>
</sec>
<sec id="s0045">
<title>Results</title>
<p id="p0055">Eventually, we selected the highest performed model, logistic regression with two features <italic>MeanBreadth</italic> and <italic>SphericalDisproportion</italic> (<xref ref-type="table" rid="t0005">Table 1</xref>). The performance metric used in this challenge was Area Under Curve (AUC), the model obtained mean AUC of 0.753 (<inline-formula><mml:math altimg="si4.gif" id="M3" overflow="scroll"><mml:mrow><mml:mo>±</mml:mo><mml:mn>0.075</mml:mn></mml:mrow></mml:math></inline-formula>) from 10-random-split on training cohort (<xref ref-type="fig" rid="f0015">Fig. 3</xref>), 0.86667 on public leaderboard, and 0.91549 on the private one. We are the only team having higher private leaderboard score than the public one, which is a good indicator of model generalizability. Due to the challenge setting that truth were not released for public and private leaderboard cohorts, we are not able to provide ROC curve for either leaderboard cohorts.<fig id="f0015"><label>Fig. 3</label><caption><p>The testing ROC curves of each fold of the 10-random-split of the training cohort.</p></caption><graphic xlink:href="gr3"></graphic></fig><table-wrap id="t0005" position="float"><label>Table 1</label><caption><p>Final logistic regression.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>Estimated odds ratio</th><th>95<inline-formula><mml:math altimg="si1.gif" id="M4" overflow="scroll"><mml:mrow><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> CI</th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td><italic>MeanBreadth</italic></td><td>0.926</td><td>[0.895, 0.958]</td><td>&lt;0.0001</td></tr><tr><td><italic>SphericalDisproportion</italic></td><td>2.045</td><td>[1.833, 2.280]</td><td>&lt;0.0001</td></tr></tbody></table></table-wrap></p>
<p id="p0060">The <italic>MeanBreadth</italic> measures the mean “width” of the ROI; therefore, it is closely related to the size of the tumor. We observed that HPV-pos subjects tend to have smaller meanBreadth (<xref ref-type="fig" rid="f0020">Fig. 4</xref>A), which indicates the tumor size is smaller in the HPV induced subjects.<fig id="f0020"><label>Fig. 4</label><caption><p>Features comparison between HPV+ and HPV− subjects. A. HPV+ patients have a relatively smaller <italic>meanBreadth</italic> comparing to HPV− patients. B. Similarly, HPV− subjects have larger <italic>SphericalDisproportion</italic> than the HPV+ subjects.</p></caption><graphic xlink:href="gr4"></graphic></fig></p>
<p id="p0065">On the other hand, <italic>SphericalDisproportion</italic> measures the ratio of the surface area of the image ROI to the surface area of a sphere with the same volume as the image ROI. This feature describes how complicated the shape of the tumor is, since simpler shape usually have smaller surface area comparing to more complicated shape, when the volumes are the same. The HPV-positive subjects also have smaller <italic>SphericalDisproportion</italic> (<xref ref-type="fig" rid="f0020">Fig. 4</xref>B), which could imply that the shape of the tumor is less complex for subjects carrying HPV than the one for subjects not carrying HPV.</p>
</sec>
<sec id="s0050">
<title>Discussion</title>
<p id="p0070">In this article, we reported our winning strategy in the 2016 Medical Image Computing and Computer Assisted Intervention (MICCAI) grand challenge: Oropharynx Cancer (OPC) Radiomics Challenge, Human Papilloma Virus (HPV) Status Prediction. The goal of the challenge is to predict HPV-16 status from annotated CT images. Our approach involves image quality checking, feature extraction, ROI reconstruction and variable selection. All through the process, we have tried various statistical models including pdfCluster, random forest, decision tree, SVM (linear and non-linear kernels) and etc. In the winning submission, we used the generalized linear model (GLM) since it had the best public leaderboard score.</p>
<p id="p0075">Besides the statistical models, we have tried deep learning as well. The network we used was GoogleNet, and the input was 2D center slice of the ROI. Although the results turned out to be not as satisfied as the statistical models, it is worth mentioning that even with only 149 subjects (actually only 75 subjects since the random split takes only half of the data as training cohort), deep learning was able to achieve AUC around 0.744 on a random split test (0.753 for the winning algorithm on the same set). The difference in AUC is marginal, and we expect that given more training subjects, deep learning will behave as well as if no better than the statistical models.</p>
<p id="p0080">Several clinical statements were also provided, but we did not use these information in our model mainly due to two reasons: firstly, our intuition was to assess the performance of using images solely, and evaluate how precise image itself can predict the HPV status; another one is including clinical information will bring in extra uncertainties into the model. For example, TNM grade requires further testing, and the grade system is discrete while tumors develop in a continuous fashion; therefore, a cutoff has to be chosen to classify the tumor into the grade system. This mandatory discretization may introduce bias and uncertainty. On the other hand, some self-reported items, e.g. smoking and sexual frequency may not be accurate. Therefore, if the clinical parameters will help improve the prediction is still debatable. There was a study <xref ref-type="bibr" rid="b0145">[29]</xref> showing that the clinical parameters themselves were able to achieve prediction AUC of 0.84 (lower than what our model can do). They have also showed that their radiomic features did not provide improvement over the clinical only model. However, they have had only a few vaguely defined imaging features, while in our study much more comprehensive radiomic features were extracted. Unfortunately, since the challenge was concluded, we no longer have access to the leaderboard, so we are not able to provide feedbacks at this time. But this issue, whether or not adding clinical parameters improve the overall prediction accuracy, worth further study.</p>
<p id="p0085">One uncommon fact is that our model has a higher AUC on the private cohort than the public cohort. On one hand we believe it is an indication of good generalizability of our model, while it could also be possible that the validation/test cohort is relatively small. Due to the setting of the challenge that we did not receive the truth of either public or private cohort, we are not able to give more information on this rare situation.</p>
<p id="p0090">From the results, we found that the subjects of HPV-pos usually have smaller and geometrically simpler tumor, hence it is more manageable. These findings may partially explain the current literature results that HPV-pos subjects have overall survival advantage <xref ref-type="bibr" rid="b0005">[1]</xref>, <xref ref-type="bibr" rid="b0010">[2]</xref>, <xref ref-type="bibr" rid="b0015">[3]</xref>.</p>
<p id="p0095">In this study, we explored the correlation between radiomic features and one clinical outcome, HPV16 status. As an exploration study, we think it provides its value by showing the high predictive ability. Beyond HPV16 status, we believe there are more connections between the underlying biology and imaging, for example quantifying tumor heterogeneity through imaging. In this scenario, clonal/subclonal composition can be identified through imaging, without getting the actual biopsy. This will help physician make better treatment decision, and potentially increase the survival chance of patients.</p>
<p id="p0100">In conclusion, we have designed a statistical framework to analyze CT images to predict HPV status, and achieved the first place in the 2016 MICCAI grand challenge: Oropharynx Cancer (OPC) Radiomics Challenge, Human Papilloma Virus (HPV) Status Prediction.</p>
</sec>
</body>
<back>
<ref-list id="bi005">
<title>References</title>
<ref id="b0005">
<label>1</label>
<element-citation id="h0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Jong</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Pramana</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Knegjens</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Balm</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>van den Brekel</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Hauptmann</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Hpv and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors</article-title>
<source/>Radiother Oncol
          <volume>95</volume>
<issue>3</issue>
<year>2010</year>
<fpage>365</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="pmid">20346528</pub-id>
</element-citation>
</ref>
<ref id="b0010">
<label>2</label>
<element-citation id="h0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ang</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>D.I.</given-names>
</name>
<name>
<surname>Nguyen-Tan</surname>
<given-names>P.F.</given-names>
</name>
</person-group>
<article-title>Human papillomavirus and survival of patients with oropharyngeal cancer</article-title>
<source/>N Engl J Med
          <volume>363</volume>
<issue>1</issue>
<year>2010</year>
<fpage>24</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">20530316</pub-id>
</element-citation>
</ref>
<ref id="b0015">
<label>3</label>
<element-citation id="h0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fakhry</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Westra</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cmelak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ridge</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial</article-title>
<source/>J Natl Cancer Inst
          <volume>100</volume>
<issue>4</issue>
<year>2008</year>
<fpage>261</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">18270337</pub-id>
</element-citation>
</ref>
<ref id="b0020">
<label>4</label>
<element-citation id="h0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Giovanello</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Predicting alzheimers disease using combined imaging-whole genome snp data</article-title>
<source/>J Alzheimer’s Dis: JAD
          <volume>46</volume>
<issue>3</issue>
<year>2015</year>
<fpage>695</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="pmid">25869783</pub-id>
</element-citation>
</ref>
<ref id="b0025">
<label>5</label>
<element-citation id="h0025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jack</surname>
<given-names>C.R.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Petersen</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Ivnik</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Prediction of ad with mri-based hippocampal volume in mild cognitive impairment</article-title>
<source/>Neurology
          <volume>52</volume>
<issue>7</issue>
<year>1999</year>
<fpage>1397</fpage>
<lpage>1403</lpage>
<pub-id pub-id-type="pmid">10227624</pub-id>
</element-citation>
</ref>
<ref id="b0030">
<label>6</label>
<element-citation id="h0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fennema-Notestine</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hagler</surname>
<given-names>D.J.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>McEvoy</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Fleisher</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Karow</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Structural mri biomarkers for preclinical and mild alzheimer’s disease</article-title>
<source/>Hum Brain Mapping
          <volume>30</volume>
<issue>10</issue>
<year>2009</year>
<fpage>3238</fpage>
<lpage>3253</lpage>
</element-citation>
</ref>
<ref id="b0035">
<label>7</label>
<element-citation id="h0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davatzikos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Batmanghelich</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
</person-group>
<article-title>Prediction of mci to ad conversion, via mri, csf biomarkers, and pattern classification</article-title>
<source/>Neurobiol Aging
          <volume>32</volume>
<issue>12</issue>
<year>2011</year>
<comment>2322.e19–27</comment>
</element-citation>
</ref>
<ref id="b0040">
<label>8</label>
<element-citation id="h0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuingnet</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gerardin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tessieras</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Auzias</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lehericy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Habert</surname>
<given-names>M.O.</given-names>
</name>
</person-group>
<article-title>Automatic classification of patients with alzheimer’s disease from structural mri: a comparison of ten methods using the adni database</article-title>
<source/>Neuroimage
          <volume>56</volume>
<issue>2</issue>
<year>2011</year>
<fpage>766</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="pmid">20542124</pub-id>
</element-citation>
</ref>
<ref id="b0045">
<label>9</label>
<element-citation id="h0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazlett</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Munsell</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Styner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Early brain development in infants at high risk for autism spectrum disorder</article-title>
<source/>Nature
          <volume>542</volume>
<issue>7641</issue>
<year>2017</year>
<fpage>348</fpage>
<lpage>351</lpage>
<pub-id pub-id-type="pmid">28202961</pub-id>
</element-citation>
</ref>
<ref id="b0050">
<label>10</label>
<element-citation id="h0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caroline</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Lung cancer screening with low dose ct</article-title>
<source/>Radiol. Clinics North Am.
          <volume>52</volume>
<issue>1</issue>
<year>2014</year>
<fpage>27</fpage>
<lpage>46</lpage>
</element-citation>
</ref>
<ref id="b0055">
<label>11</label>
<element-citation id="h0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aberle</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Clapp</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Fagerstrom</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Reduced lung-cancer mortality with low-dose computed tomographic screening</article-title>
<source/>N Engl J Med
          <volume>365</volume>
<issue>5</issue>
<year>2011</year>
<fpage>395</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="pmid">21714641</pub-id>
</element-citation>
</ref>
<ref id="b0060">
<label>12</label>
<element-citation id="h0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindfors</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Boone</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>A.L.C.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Dedicated breast ct: initial clinical experience</article-title>
<source/>Radiology
          <volume>246</volume>
<issue>3</issue>
<year>2008</year>
<fpage>725</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="pmid">18195383</pub-id>
</element-citation>
</ref>
<ref id="b0065">
<label>13</label>
<element-citation id="h0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aerts</surname>
<given-names>H.J.W.L.</given-names>
</name>
<name>
<surname>Velazquez</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Leijenaar</surname>
<given-names>R.T.H.</given-names>
</name>
<name>
<surname>Parmar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Grossmann</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach</article-title>
<source/>Nat Commun
          <volume>5</volume>
<year>2014</year>
<fpage>4006</fpage>
<pub-id pub-id-type="pmid">24892406</pub-id>
</element-citation>
</ref>
<ref id="b0070">
<label>14</label>
<element-citation id="h0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cantrell</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Peck</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sturgis</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Ginsberg</surname>
<given-names>L.E.</given-names>
</name>
</person-group>
<article-title>Differences in imaging characteristics of hpv-positive and hpv-negative oropharyngeal cancers: a blinded matched-pair analysis</article-title>
<source/>AJNR. Am J Neuroradiol
          <volume>34</volume>
<issue>10</issue>
<year>2013</year>
<fpage>2005</fpage>
<lpage>2009</lpage>
<pub-id pub-id-type="pmid">23660291</pub-id>
</element-citation>
</ref>
<ref id="b0075">
<label>15</label>
<mixed-citation id="h0075" publication-type="other">Buch K, Fujita A, Li B, Kawashima Y, Qureshi M, Sakai O, Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on ct. Am J Neuroradiol36(7); 2015, pp. 1343–1348. arXiv: <ext-link ext-link-type="uri" id="ir010" xlink:href="http://www.ajnr.org/content/36/7/1343.full.pdf">http://www.ajnr.org/content/36/7/1343.full.pdf</ext-link>.<ext-link ext-link-type="doi" id="ir015" xlink:href="10.3174/ajnr.A4285">https://doi.org/10.3174/ajnr.A4285</ext-link>. URL<ext-link ext-link-type="uri" id="ir020" xlink:href="http://www.ajnr.org/content/36/7/1343">http://www.ajnr.org/content/36/7/1343</ext-link>.</mixed-citation>
</ref>
<ref id="b0080">
<label>16</label>
<mixed-citation id="h0080" publication-type="other">Bogowicz M, Riesterer O, Ikenberg K, Stieb S, Moch H, Studer G. et al., Computed tomography radiomics predicts hpv status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys.<ext-link ext-link-type="doi" id="ir025" xlink:href="10.1016/j.ijrobp.2017.06.002">https://doi.org/10.1016/j.ijrobp.2017.06.002</ext-link>. URL<ext-link ext-link-type="uri" id="ir030" xlink:href="http://www.sciencedirect.com/science/article/pii/S0360301617310118">http://www.sciencedirect.com/science/article/pii/S0360301617310118</ext-link>.</mixed-citation>
</ref>
<ref id="b0085">
<label>17</label>
<element-citation id="h0085" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fried</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Fave</surname>
<given-names>X.J.</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Court</surname>
<given-names>L.E.</given-names>
</name>
</person-group>
<article-title>Ibex: an open infrastructure software platform to facilitate collaborative work in radiomics</article-title>
<source/>Med Phys
          <volume>42</volume>
<issue>3</issue>
<year>2015</year>
<fpage>1341</fpage>
<lpage>1353</lpage>
<pub-id pub-id-type="pmid">25735289</pub-id>
</element-citation>
</ref>
<ref id="b0090">
<label>18</label>
<mixed-citation id="h0090" publication-type="other">Matched computed tomography segmentation and demographic data for oropharyngeal cancer radiomics challenges 4 (2017) 170077.<ext-link ext-link-type="doi" id="ir035" xlink:href="10.1038/sdata.2017.77">https://doi.org/10.1038/sdata.2017.77</ext-link>.<ext-link ext-link-type="uri" id="ir040" xlink:href="https://www.nature.com/articles/sdata201777#supplementary-information">https://www.nature.com/articles/sdata201777#supplementary-information</ext-link>.</mixed-citation>
</ref>
<ref id="b0095">
<label>19</label>
<mixed-citation id="h0095" publication-type="other">Grubbs FE, Procedures for detecting outlying observations in samples, Technometrics 11 (1), c6758 Times Cited:1461 Cited References Count:15.</mixed-citation>
</ref>
<ref id="b0100">
<label>20</label>
<element-citation id="h0100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilcoxon</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Individual comparisons by ranking methods</article-title>
<source/>Biometrics Bull
          <volume>1</volume>
<issue>6</issue>
<year>1945</year>
<fpage>80</fpage>
<lpage>83</lpage>
</element-citation>
</ref>
<ref id="b0105">
<label>21</label>
<element-citation id="h0105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mann</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Whitney</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>On a test of whether one of two random variables is stochastically larger than the other</article-title>
<source/>Ann Math Stat
          <year>1947</year>
<fpage>50</fpage>
<lpage>60</lpage>
</element-citation>
</ref>
<ref id="b0110">
<label>22</label>
<element-citation id="h0110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolmogorov</surname>
<given-names>A.N.</given-names>
</name>
</person-group>
<article-title>Sulla determinazione empirica di una legge di distribuzione</article-title>
<source/>Giornale dell’Istituto Italiano degli Attuari
          <volume>4</volume>
<year>1933</year>
<fpage>83</fpage>
<lpage>91</lpage>
<comment>doi:citeulike-article-id:1213059</comment>
</element-citation>
</ref>
<ref id="b0115">
<label>23</label>
<element-citation id="h0115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smirnov</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Table for estimating the goodness of fit of empirical distributions</article-title>
<source/>Ann Math Stat
          <year>1948</year>
<fpage>279</fpage>
<lpage>281</lpage>
</element-citation>
</ref>
<ref id="b0120">
<label>24</label>
<element-citation id="h0120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelder</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Wedderburn</surname>
<given-names>R.W.M.</given-names>
</name>
</person-group>
<article-title>Generalized linear models</article-title>
<source/>J R Stat Soc Ser A (General)
          <volume>135</volume>
<issue>3</issue>
<year>1972</year>
<fpage>370</fpage>
<lpage>384</lpage>
</element-citation>
</ref>
<ref id="b0125">
<label>25</label>
<element-citation id="h0125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Azzalini</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>An advancement in clustering via nonparametric density estimation</article-title>
<source/>Stat Comput
          <volume>24</volume>
<issue>5</issue>
<year>2014</year>
<fpage>753</fpage>
<lpage>767</lpage>
</element-citation>
</ref>
<ref id="b0130">
<label>26</label>
<element-citation id="h0130" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Quinlan</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<chapter-title>Learning efficient classification procedures and their application to chess end games</chapter-title>
<year>1983</year>
<publisher-name>Springer</publisher-name>
<publisher-loc>Berlin Heidelberg</publisher-loc>
<fpage>463</fpage>
<lpage>482</lpage>
</element-citation>
</ref>
<ref id="b0135">
<label>27</label>
<element-citation id="h0135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breiman</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Random forests</article-title>
<source/>Mach Learn
          <volume>45</volume>
<issue>1</issue>
<year>2001</year>
<fpage>5</fpage>
<lpage>32</lpage>
</element-citation>
</ref>
<ref id="b0140">
<label>28</label>
<mixed-citation id="h0140" publication-type="other">Boser BE, Guyon IM, Vapnik VN, A training algorithm for optimal margin classiffers; 1992.<ext-link ext-link-type="doi" id="ir045" xlink:href="10.1145/130385.130401">https://doi.org/10.1145/130385.130401</ext-link>.</mixed-citation>
</ref>
<ref id="b0145">
<label>29</label>
<element-citation id="h0145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Waldron</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Morphologic and topographic radiologic features of human papillomavirus-related and unrelated oropharyngeal carcinoma</article-title>
<source/>Head Neck
          <volume>39</volume>
<issue>8</issue>
<year>2017</year>
<fpage>1524</fpage>
<lpage>1534</lpage>
<pub-id pub-id-type="pmid">28580605</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="s0010" sec-type="supplementary-material">
<title>Supplementary data</title>
<p id="p0110">
<supplementary-material content-type="local-data" id="m0005">
<media xlink:href="mmc1.xml"></media>
</supplementary-material>
</p>
<p id="p0115">
<supplementary-material content-type="local-data" id="m0010">
<media xlink:href="mmc2.xlsx"></media>
</supplementary-material>
</p>
</sec>
<ack id="ak005">
<title>Acknowledgments</title>
<p>We would like to thank the editor and reviewers for their constructive comments to help us improve this manuscript. HZ’s research was partially supported by <funding-source id="gp005">NIH</funding-source> Grant MH086633, <funding-source id="gp010">NSF</funding-source> Grants SES-1357666 and DMS-1407655, and a Grant from <funding-source id="gp015">Cancer Prevention Research Institute of Texas</funding-source>. VB’s research was partially supported by NIH Grants R01-CA194391 and R01160736, NSF Grant 1463233 and <funding-source id="gp020">Cancer Center Support Grant</funding-source> (CCSG) from NIH/NCI (P30-CA016672). JSM’s efforts were supported by <funding-source id="gp025">NCI</funding-source> Grants CA-178744, CA-160736, and CA-016672, and <funding-source id="gp030">NSF-Bio/BBSRC</funding-source> Grant 1550088. We would like to thank the organizers: Clifton D Fuller, MD, PhD (Team Lead), Hesham ElHalawani, MD, MSc, Abdallah Mohamed, MD, MSc, Aubrey White, BS, James Zafereo, BS, Andrew Wong, BS, Joel Berends, BS, Shady Abohashem, MD, Bowman Williams, BS, Jeremy Aymard, BS, Aasheesh Kanwar, BS and Subha Perni, BS (MD Anderson Cancer Center); MGH: Jayashree Kalpathy-Cramer,PhD; NCI: Keyvan Farahani, PhD, John Freymann, PhD for making this challenge possible.</p>
</ack>
<fn-group>
<fn fn-type="supplementary-material" id="s0005">
<label>Appendix A</label>
<p id="p0105">Supplementary data associated with this article can be found, in the online version, at<ext-link ext-link-type="doi" id="ir005" xlink:href="10.1016/j.ctro.2017.10.001">https://doi.org/10.1016/j.ctro.2017.10.001</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>